🧬 Benjamin Arya interviews me about my research on gene therapy delivery systems, about my first startup company Cathedral Therapeutics (see link to website and a bit about my newer venture towards solving the brain delivery problem.

“Putting an AAV inside of a protein vault shields the AAV from the preexisting antibodies that humans produce.”